Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Achilles' heel of cancer?

× No keyword cloud information.

16 in total

1. Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.

Authors: Jacqueline Lehmann-Che; Fabrice André; Christine Desmedt; Chafika Mazouni; Sylvie Giacchetti; Elisabeth Turpin; Marc Espié; Louis-François Plassa; Michel Marty; Philippe Bertheau; Christos Sotiriou; Martine Piccart; W Fraser Symmans; Lajos Pusztai; Hugues de Thé
Journal: Oncologist Date: 2010-03-12

2. AAV Infection: Protection from Cancer.

Authors: Arun Srivastava; Barrie J Carter
Journal: Hum Gene Ther Date: 2016-11-10 Impact factor: 5.695

3. Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.

Authors: Nageswara R Pulipati; Qunyan Jin; Xin Liu; Baodong Sun; Manoj K Pandey; Jonathan P Huber; Wei Ding; Kathleen M Mulder
Journal: Int J Cancer Date: 2011-04-25 Impact factor: 7.396

4. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

Authors: Christin E Petre; Sang-Hoon Sin; Dirk P Dittmer
Journal: J Virol Date: 2006-11-22 Impact factor: 5.103

5. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

Authors: Wenge Wang; Rishu Takimoto; Farzan Rastinejad; Wafik S El-Deiry
Journal: Mol Cell Biol Date: 2003-03 Impact factor: 4.272

Achilles' heel of cancer?

1. Cyclophosphamide dose intensification may circumvent anthracycline resistance of p53 mutant breast cancers.

2. AAV Infection: Protection from Cancer.

3. Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.

4. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy.

5. Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.

6. PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition.

Review 7. p53 as an Effector or Inhibitor of Therapy Response.

8. Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

9. Lack of p53 function promotes radiation-induced mitotic catastrophe in mouse embryonic fibroblast cells.

10. A constitutively active and uninhibitable caspase-3 zymogen efficiently induces apoptosis.